MCOLN3 and non-small cell lung carcinoma: In addition, Baicalin inhibits non-small-cell lung cancer (NSCLC) proliferation by activating the lysosomal Ca2+ channel MCOLN3, disrupting Ca2+ homeostasis, and impairing autolysosomal degradation [142].